Literature DB >> 7941844

Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.

C Buonavoglia1, A Cavalli, E Gravino, V Voigt, D Buonavoglia, D de Caprariis.   

Abstract

The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty-five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100%, 72.7% and 17.6% in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7941844     DOI： 10.1111/j.1439-0450.1994.tb00199.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN： 0514-7166


  2 in total

1.  Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies.

Authors:  Vito Martella; Alessandra Cavalli; Nicola Decaro; Gabriella Elia; Costantina Desario; Marco Campolo; Giancarlo Bozzo; Elvira Tarsitano; Canio Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

2.  Exclusive circulation of canine parvovirus type 2c in the Guadalajara metropolitan area in western Mexico: a five-year study.

Authors:  César Pedroza-Roldán; Martín Alejandro Hernández-Almaraz; Darwin Elizondo-Quiroga; Abel Gutierrez-Ortega; Carlos Maximiliano Acosta-Monroy; Claudia Charles-Niño; Mauricio Realpe-Quintero; Sandra Del Carmen Robles-Gil
Journal:  Arch Virol       Date:  2022-07-06       Impact factor: 2.685
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.